Start | Browse by Program | Author Index

Genomics/Metabolomics/Proteomics

P171
Comparison of the Effects of All-Trans-Retinoic Acid in HepG2 and MCF7 Cells Using Semi-Quantitative Shotgun Proteomics
Samuel L.M. Arnold, University of Washington; John D. Chapman, University of Washington; David R. Goodlett, University of Washington; Nina Isoherranen, University of Washington
P172
Global Transcriptomic Profiling of LPS, TNFα, and IL-4 in Primary Human Hepatocytes
Michael J. Liguori, Abbott Laboratories; Rita Ciurlionis, Abbott Laboratories; Amy C. Ditewig, Abbott Laboratories; Eric A.G. Blomme, Abbott Laboratories; Yi Yang, Abbott Laboratories
P173
Metabolic Effects of Naphthalene on Mouse Urine Using NMR-based Metabolomics
Ching-yu Lin, National Taiwan University; Hao-Jan Liang, National Taiwan University
P174
Metabolomic study of the organophosphates and the antidotes by using LC-MS/MS
Shan Jin, Harvard Medical School
P175
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action
Mateja Hafner, University of Ljubljana, Center for Functional Genomics and Bio-Chips; Peter Juvan, University of Ljubljana, Center for Functional Genomics and Bio-Chips; Tadeja Rezen, University of Ljubljana, Center for Functional Genomics and Bio-Chips; Katalin Monostory, Chemical Research Center, Hungarian Academy of Sciences; Jean-Marc Pascussi, INSERM U661; Damjana Rozman, University of Ljubljana, Center for Functional Genomics and Bio-Chips
P176
The identification of novel in vivo preclinical biomarkers for metabolism mediated toxicity using two distinct, eletrophilic near-infrared fluorophores
Brooke M. VandenBrink, Amgen Inc; Helen J. McBride, Amgen Inc; Marcus D. Soto, Amgen Inc; Alexandra Ioanoviciu, Amgen Inc; Dan A. Rock, Amgen Inc
See more of: Poster and Oral Presentations
<< Previous Session | Next Session >>